Press Releases

MaaT Pharma and Biocodex to industrialize FMT & develop an oral formulation

By MaaT Pharma June 8, 2017 No Comments

See More

Previous PostMaaT Pharma announces CE marking for its medical device
Next PostLa Dysbiose

© 2021 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases